Drug Profile
Research programme: malonyl coenzyme A decarboxylase inhibitors - Chugai
Alternative Names: CBM-300864; CBM-301940Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Chugai Pharmaceutical
- Class
- Mechanism of Action Malonyl CoA decarboxylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Coronary disorders
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Coronary-disorders in USA (IV)
- 01 Jul 2006 This programme is still in active development